There are new treatments to help patients with glaucoma, and they’re just in time. The disease is the second leading cause of ...

Extended preoperative use of topical glaucoma medications with preservatives may negatively affect long-term trabeculectomy ...

In a phase 3 trial, Tenpoint Therapeutics’ eye drop—a combination of carbachol and brimonidine—improved vision for patients ...

A new study presented Oct. 20 at AAO 2024 ... compared selective laser trabeculoplasty and glaucoma eye drops as first-line ...

The American Glaucoma Society and American Academy of Ophthalmology are warning eye doctors to be aware of potentially toxic ...

Glaucoma is a common eye condition that can affect people as they age, especially those over 60. It damages the optic nerve, ...

The condition is typically treated using drugs delivered via eye drops to help decrease ... represents a potentially exciting new alternative to existing glaucoma treatments.

Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD. Jonathan Eisengart, MD, an ophthalmologist at Cleveland Clinic, explained how different ...

Glaucoma is the leading cause of blindness worldwide. Its symptoms do not present themselves in an obvious way, which has led to the condition being dubbed the ‘silent thief of sight’.

More than 3 million people in the U.S. are estimated to be living with glaucoma. By 2030, that number is expected to increase ...

Background Normal tension glaucoma ... right eye was used for statistical analysis. Results In 41 right eyes, the mean pre-study IOP was 14.3 ± 3.4 mmHg while on 1.5 ± 0.8 eye drops.

About 70% of patients are able to get rid of one eye drop after they receive the iStent. A new novel treatment modality for glaucoma has been approved by the FDA to help patients who have a ...